"Dr. med. C. Hielscher I Dr. med A. Jonas Fachärzte für Frauenheilkunde und Geburtshilfe Onkologische Therapie – Tagesklinik Brustzentrum Studiensekretariat Gynäkologische Praxis SP Gynäkologische Onkologie Medikamentöse Tumortherapie Spezielle Operative Gynäkologie Palliativmedizin weitere Leistungen: Gynäkologische Sprechstunde Schwangerschaftsbetreuung Mammasonographie Urogynäkologie Impfungen"

During the past decade, Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "AGO Research GmbH" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "University Hospital Tuebingen" with 2 trials sponsored and "iOMEDICO AG" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher" are "Breast Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials), "Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Breast Neoplasms" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher" in a lesser frequency.

Most popular intervention types in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher" are "Drug" (10 trials), "Biological" (1 trials), "Combination Product" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials), "Atezolizumab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher" are 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gynäkologie Kompetenzzentrum Praxis Dr. med. Carsten Hielscher, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".